fda compounding glp-1 enforcement news november 2025 is moving to restrict mass-marketed compounded products that aren't FDA-approved, warning companies they can't market them as equivalent to approved drugs and signaling stronger to protect patients from unverified Diabetes advocacy group discourages use

Semaglutide or Tirzepatide Weight-Loss Program with Consultation

Single Chinese military hospital records (2012-2023)

Wondering if you can take topiramate and Zepbound together

Dexcom G7 Sensors and G7 Receiver Bundle

However, further research is needed to fully understand how these therapies exert their effect on body weight and in the last section we cover open questions about the potential mechanisms of multiagonist drugs, and the understanding of how gutbrain communication can be leveraged to achieve sustained body weight loss without adverse effects.

Phase 3 programmes also evaluated long-term safety, tolerability, and metabolic outcomes, forming the basis for subsequent regulatory approvals in certain jurisdictions